Showing results (611-620 of 885) with videos related to
Sort By:
Pageof 89
Vaccine|November 17, 2015
Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adultsMarilia Santini-Oliveira, Rhea N Coler, Juçara Parra, et al.Plos One|May 24, 2013
Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cellsKatie Matthews, Nancy P Y Chung, Per Johan Klasse, et al.Investigative Radiology|March 1, 1994
Attenuation of monochromatic X-rays by normal and abnormal breast tissuesF E Carroll, J W Waters, W W Andrews, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2018
Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist ActivityAmit Michaeli, Shaul Mezan, Andreas Kühbacher, et al.Vaccine|September 26, 2016
Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvantRobert G Schaut, Tara L Grinnage-Pulley, Kevin J Esch, et al.Journal of Clinical Microbiology|September 2, 2000
Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCGD C Dillon, M R Alderson, C H Day, et al.Cancer Research|April 5, 2000
Identification of differentially expressed genes in human prostate cancer using subtraction and microarrayJ Xu, J A Stolk, X Zhang, et al.Experimental Cell Research|March 1, 2000
Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cellsJ G Culvenor, G Evin, M A Cooney, et al.Plos One|July 26, 2012
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140Mauricio A Arias, Griet A Van Roey, John S Tregoning, et al.Vaccine|March 9, 2010
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SEJoelma Trigo, Melissa Abbehusen, Eduardo M Netto, et al.Pageof 89